STAAR Surgical Announces First Quarter 2014 Results Release Date, Conference Call and Webcast

Apr 17, 2014, 07:00 ET from STAAR Surgical Company

MONROVIA, Calif., April 17, 2014 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye,  today announced that it will release its financial results for the first quarter ended April 4, 2014 on Monday, April 28, 2014 after the market close.

STAAR will host a conference call and video webcast on Monday, April 28 at 4:15 p.m. Eastern / 1:15 p.m. Pacific to discuss these results and recent corporate developments. The dial-in number for the conference call is 866-202-0886 for domestic participants and 627-213-8841 for international participants, both using the passcode 15014292.  The Company will broadcast the event live from its booth on the Exhibitor Floor at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Symposium and Congress. The live video webcast with accompanying slides can be accessed from the investor relations section of the STAAR website at  

A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will be available for seven days.  This replay can be accessed by dialing 888-286-8010 for domestic callers and 617-801-6888 for international callers, both using passcode 94266534.  An archived video webcast will also be available at

About STAAR Surgical STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." More than 400,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: STAAR has approximately 335 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company's website at

Collamer® is the registered trademark for STAAR's proprietary biocompatible collagen copolymer lens material. 

CONTACT:    Investors      


                     EVC Group                     

EVC Group

                     Doug Sherk, 415-652-9100

Nicole Kruse

                     Leigh Salvo, 415-568-9348  


SOURCE STAAR Surgical Company